It is well established that an aberrant expression of the PI3K/Akt/mTOR pathway plays a pivotal role in cancer cell proliferation, survival and chemotherapy resistance through the alteration of physiologic cell cycle progression, differentiation and growth13, 19, 37. The gene discussed is AKT1; the disease is cancer.